oVRcome - Self Guided Virtual Reality for Social Anxiety Disorder
1 other identifier
interventional
100
1 country
1
Brief Summary
Social anxiety is characterised by excessive fear of being negatively judged, embarrassed or humiliated during social interactions and is common with a lifetime prevalence of 12.1%. Cognitive behavioural therapy is the first line of treatment, but people may not seek treatment due to a number of factors including the discomfort experienced in seeking help, inconvenience, and the experience of psychotherapy itself. With Virtual Reality (VR), users can have increased control in how gradually they expose themselves to social situations. In studies of VR in people with specific phobias, 76% of people prefer VR exposure to in vivo exposure. There is emerging evidence for the use of VR in social phobia. oVRcome, is a self-help VRET for social anxiety symptoms and specific phobias, that is delivered through a smartphone application (app) in combination with a low cost headset that holds the smartphone and uses 360º video. This study will evaluate the effectiveness of the oVRcome social anxiety program for social anxiety symptoms. We hypothesize that oVRcome will reduce social anxiety symptom severity over a 6-week treatment period compared to waiting-list control
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 8, 2022
CompletedFirst Submitted
Initial submission to the registry
October 9, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedApril 9, 2025
November 1, 2023
9 months
October 9, 2022
April 6, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Liebowitz social anxiety scale -self report (LSAS)
Assesses the way that social phobia plays a role in participants life across a variety of situations. Higher scores indicate more severe symptoms. Min 0 Max 144
Week 6
Secondary Outcomes (6)
Brief Fear of Negative Evaluation Scale
week 0,6,12,18
Patient's Global Impressions of Improvement (PGI-I) scale
Week 1,2,3,4,5,6,7,8,9,10,11,12,18
Patient Health Questionnaire - PHQ 9
Week 0,6,12,18
Modified Gatineau Presence Questionnaire First item
Week 4,5,6
Fast Motion Sickness Scale (FMS)
Week 4,5,6
- +1 more secondary outcomes
Study Arms (2)
Smartphone application (app) in combination with headset
EXPERIMENTALThe intervention oVRcome is self-help VRET for social anxiety, that is delivered through a smartphone application (app) in combination with headset that holds the smartphone and uses 360º video. oVRcome includes 6 modules of psychoeducation, relaxation, mindfulness, cognitive techniques, exposure through VR, and a relapse prevention module which are aimed to be completed weekly.
Waitlist
NO INTERVENTIONParticipants in the waitlist condition will be offered the intervention directly after post-test.
Interventions
The intervention oVRcome is self-help VRET for social anxiety, that is delivered through a smartphone application (app) in combination with headset that holds the smartphone and uses 360º video. oVRcome includes 6 modules of psychoeducation, relaxation, mindfulness, cognitive techniques, exposure through VR, and a relapse prevention module which are aimed to be completed weekly.
Eligibility Criteria
You may qualify if:
- are between 18-64 years old
- have moderate (or higher) social anxiety disorder symptoms on Liebowitz social anxiety scale (\>60)
- have access to a smart phone and internet
- willing to participate in the research study and providing informed consent
You may not qualify if:
- present with symptoms of severe depression or suicidality respectively as measured with the PHQ-9; total score \> 19, =3 on suicidality item
- have insufficient knowledge of the English language
- are under current treatment for social phobia or psychotropic medication (unless on stable dosage for the previous 3 months and no changes planned during the study period).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Otagolead
- oVRcomecollaborator
Study Sites (1)
University of Otago
Christchurch, 8001, New Zealand
Related Publications (1)
Lacey C, Frampton C, Beaglehole B. A self-guided virtual reality solution for social anxiety: Results from a randomized controlled study. J Psychiatr Res. 2024 Dec;180:333-339. doi: 10.1016/j.jpsychires.2024.10.032. Epub 2024 Nov 4.
PMID: 39515186DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Cameron Lacey, PhD
University of Otago, Christchurch
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2022
First Posted
October 12, 2022
Study Start
October 8, 2022
Primary Completion
July 1, 2023
Study Completion
November 1, 2023
Last Updated
April 9, 2025
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share